ADVENTHEALTH PALM COAST
1. Target Overview & Investment Thesis
ADVENTHEALTH PALM COAST is a 99-bed suburban community hospital in FLAGLER, FL with $285.7M in net patient revenue and a 8.1% operating margin. The hospital serves a payer mix of 33.9% Medicare, 1.7% Medicaid, and 64.4% commercial.
Thesis: Turnaround. Our ML models identify $21.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.1% to 15.5% (+736bps).
| Net Revenue HCRIS | $285.7M |
| Current EBITDA COMPUTED | $23.2M |
| Operating Margin COMPUTED | 8.1% |
| Occupancy HCRIS | 130.2% |
| Revenue / Bed COMPUTED | $2.9M |
| Net-to-Gross HCRIS | 24.3% |
| Distress Probability ML | 27.7% |
2. Market Context & Competitive Position
FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 8.1% places it above the state median. Among 117 size-comparable peers (50-198 beds), the median margin is 4.7%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (50-198), prioritizing same-state peers. 117 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ADVENTHEALTH PALM COAST (Target) | FL | 99 | $285.7M | 8.1% |
| WEST KENDALL BAPTIST HOSPITAL | FL | 127 | $361.6M | 18.5% |
| ADVENTHEALTH WESLEY CHAPEL | FL | 169 | $360.1M | 17.0% |
| ORLANDO HEALTH SOUTH LAKE HOSP | FL | 167 | $331.8M | 7.2% |
| HOMESTEAD HOSPITAL | FL | 159 | $270.4M | -11.1% |
| NEMOURS CHILDRENS HOSPITAL | FL | 130 | $268.7M | -10.2% |
| MEMORIAL HOSPITAL MIRAMAR | FL | 178 | $267.4M | 14.0% |
| DOCTORS HOSPITAL | FL | 130 | $250.0M | 0.9% |
| WEST BOCA MEDICAL CENTER | FL | 195 | $224.0M | 19.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $21.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $6.0M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $5.7M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $5.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $3.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $183K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $23.2M |
| + RCM Uplift | +$21.0M |
| Pro Forma EBITDA | $44.3M |
| Current Margin | 8.1% |
| Pro Forma Margin | 15.5% |
| WC Released (1x) | $11.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $35.8M | $363.6M | 10.17x | 59.0% |
| Base (11x exit) | 10.0x | 11.0x | $35.8M | $411.6M | 11.51x | 63.0% |
| Bull Case | 9.0x | 11.0x | $32.2M | $492.6M | 15.31x | 72.6% |
| Bull (12x exit) | 9.0x | 12.0x | $32.2M | $546.9M | 16.99x | 76.2% |
| Bear Case | 11.0x | 10.0x | $39.3M | $246.9M | 6.28x | 44.4% |
| Bear (11x exit) | 11.0x | 11.0x | $39.3M | $284.3M | 7.23x | 48.5% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 117 hospitals with 50-198 beds
- Same-state prioritization (n=118)
- Comp margins: P25=-7.4% / P50=4.7% / P75=14.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.